Read the latest from Baszucki Group and its partners.
July 18, 2022 — The Baszucki Brain Research Fund is pleased to announce that five science teams around the globe have received funding to study ketogenic metabolic interventions for bipolar disorder, schizophrenia and major depressive disorder.
July 7, 2022 — This 5-minute NBC segment showcases another promising area the Baszuckis have invested in: a more targeted approach to Transcranial Magnetic Stimulation (TMS), facilitated by Magnus Medical. The company was able to end their FDA study early because the results were so impactful — 80% of depressed patients went into remission.
May 3, 2022 — During an appearance at the annual Milken Institute Global Conference, David Baszucki explained why he and his family decided to direct a portion of their philanthropy to mental health research.
April 7, 2022 — David Baszucki and Jan Ellison Baszucki and other contributors raised more than $139 million for the Save the Redwoods League’s Forever Forest campaign to protect California’s coast redwood and giant sequoia ranges.